Where’s The Beef? China Pushes For More Stringent Controls On Veterinary Drugs
This article was originally published in PharmAsia News
A draft proposal by the Ministry of Agriculture comes at a time when several Big Pharma are pursuing opportunities in China’s veterinary market.
You may also be interested in...
Pfizer Inc. announced a joint venture Sept. 8 with China's Jilin Guoyuan Animal Heatlh Company, Ltd. to develop, manufacture and distribute animal health vaccines in China
Sanofi Diversifies In China With $70 Million To Expand Production Capability For Animal Health Division Merial
SHANGHAI - Sanofi-Aventis' animal health division Merial Animal Health broke ground on a $70 million expansion of its Nanchang manufacturing site, six months after Sanofi CEO Chris Viehbacher said his company aims to diversify in China
Boehringer Ingelheim To Channel €100 Million Into Shanghai To Expand Production, Strengthen Quality Controls On APIs From China
SHANGHAI - Germany's Boehringer Ingelheim recently announced it would funnel a new €100 million ($ 150 million) investment into China to increase production capacity at its plant in the Shanghai Zhangjiang Hi-Tech Park and to introduce state-of-the-art quality control technology for active pharmaceutical ingredients sourced from China